Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC approves Eckerd sale

This article was originally published in The Tan Sheet

Executive Summary

FTC has completed its review of J.C. Penney's sale of its Eckerd drug store operations to The Jean Coutu Group, and CVS and has granted an early termination of the waiting period under Hart-Scott-Rodino, J.C. Penney announces June 1. The transaction is on track to close by the end of the year, firm adds. J.C. Penney announced the sale in early April (1"The Tan Sheet" April 12, 2004, p. 7)...

You may also be interested in...



Eckerd Drug Chain Split; Canada’s Jean Coutu, CVS Jump At Low Selling Price

The Jean Coutu Group is competitively positioned in the North American retail pharmacy market after its $2.4 bil. acquisition of Eckerd drug stores

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096908

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel